TORONTO STOCK EXCHANGE · EPRX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc

Biotechnology
$6.73
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
EPRX
Eupraxia Pharmaceuticals Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

37/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is EPRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading EPRX catalysts
About Eupraxia Pharmaceuticals Inc
Biotechnology
Listed since
2021
Employees
49
Country
CA

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs. Currently, the company has two distinct clinical development programs, one targeting EoE and the second targeting chronic Osteoarthritis pain in the knee and has completed a Phase 2b clinical trial with EP-104IAR in knee OA.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$6.73
Last session
Day high
$6.73
Last session
Day low
$6.73
Last session
Previous close
$6.73
52W high
$9.07
-25.80% from high
52W low
$5.05
42% of range
Market cap
$443.6M
EPS
$-0.9646
Beta
1.41
Shares out
65.9M
Avg volume
326.5K
VWAP
$6.73
Last session
Price history computed in-house
1W
-1.32%
1M
+15.83%
3M
-10.62%
1Y
+27.49%
YTD
-10.86%
SMA 50 $6.49 · above
SMA 200 $7.08 · below
52W position 42%

EPRX overview

Veridion Score
37
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around EPRX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading EPRX Form 4 filings
Public disclosures

Congress activity in EPRX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for EPRX in the cached public ledger.

Federal contracts

EPRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EPRX in this window.
Lobbying spend

EPRX lobbying filings, year to date.

Registered lobbying filings matched to Eupraxia Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EPRX in this window.
Loading news for EPRX
Analyst ratings
Sovereign unlock shows live analyst consensus for EPRX.
Options
Sovereign unlock shows live options positioning for EPRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.